Endoceutics - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsEndoceutics

Endoceutics

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Intrarosa	Prasterone	2018-01-08	2028-2031	Adrenal insufficiency , Dyspareunia , Postmenopause , Sexual and gender disorders , Lupus vulgaris

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

atrophic vaginitis

,

physiological sexual dysfunction

,

psychological sexual dysfunctions

,

breast neoplasms

,

,

,

Bos taurus adrenal cortex corticosteroids

lupus nephritis

type 1 diabetes mellitus

,

menstruation disturbances

,

pharmacokinetics

,

drug-related side effects and adverse reactions

,

metabolic side effects of drugs and substances

,

synovial sarcoma

,

triple negative breast neoplasms

,

,

male breast neoplasms

,

post-traumatic stress disorders

,

,

pulmonary arterial hypertension

,

substance withdrawal syndrome

,

,

erectile dysfunction

,

,

,

multiple myeloma

,

plasma cell neoplasms

,

,

autoimmune diseases

,

,

lacrimal apparatus diseases

,

salivary gland diseases

,

,

depressive disorder

,

,

,

,

,

rectal neoplasms

,

systemic lupus erythematosus

,

primary ovarian insufficiency

,

physiological sexual dysfunction

,

,

communicable diseases

,

,

female infertility

,

,

,

psychological sexual dysfunctions

,

,

metabolic bone diseases

,

connective tissue diseases

,

immune system diseases

,

,

endocrine system diseases

,

urinary tract infections

,

ovulation induction

,

,

uterine cervical neoplasms

,

vaginal neoplasms

,

vulvar neoplasms

,

anxiety disorders

,

pulmonary hypertension

,

chronic obstructive pulmonary disease

,

healthy volunteers/patients

,

,

falciparum malaria

,

endometrial neoplasms

,

fallopian tube neoplasms

,

female genital neoplasms

,

ovarian epithelial carcinoma

,

,

anorexia nervosa

,

sexual and gender disorders

,

,

myotonic dystrophy

,

addison disease

,

,

,

atrophic vaginitis

,

breast neoplasms

,

,

hyperandrogenism

,

adrenal insufficiency

,

sjogren's syndrome

,

,

,

contraception behavior

,

blood coagulation

,

,

,

,

,

pituitary acth hypersecretion

,

insulin resistance

,

polycystic ovary syndrome

,

,

,

,

,

multiple sclerosis

,

brain neoplasms

,

,

,

central nervous system neoplasms

,

medulloblastoma

,

,

,

,

,

oligodendroglioma

,

,

severe acute respiratory syndrome

,

professional burnout

,

caregiver burden

,

,

psychological stress

,

physiological stress

,

,

postmenopausal osteoporosis

,

,

,

cardiovascular diseases

,

coronary disease

,

,

adrenal gland neoplasms

,

fertilization in vitro

,

,

,

,

epidermolysis bullosa simplex

,

epidermolysis bullosa

,

disorders of sex development

,

epidermolysis bullosa dystrophica

,

junctional epidermolysis bullosa

,

turner syndrome

,

gonadal dysgenesis

,

dietary supplements

,

autism spectrum disorder

,

post-acute covid-19 syndrome

,

,

,

,

,

,

,

ureaplasma infections

,

bacterial vaginosis

,

,

lichen sclerosus et atrophicus

,

,

,

urinary calculi

,

atherosclerosis

,

,

,

,

,

peri-implantitis

,

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use